TipRanks
Go Ultimate55% OFF

Google Medical - Pharmaceuticals Profile - TipRanks - Google Analyst

4 Followers

Google Medical - Pharmaceuticals's Stock Coverage

FFR
FF EAI Robotics Ecosystem Inc
――――27Ratings0%-19.85%
INBP
Integrated BioPharma
Nov 01, 2026HOLDReiterated$0.1721Ratings――
MYX
Mayne Pharma Group
Nov 01, 2026HOLDReiteratedAU$2.5018Ratings――
ADOCY
Adocia
Nov 01, 2026SELLReiterated$3.0022Ratings――
LFST
Lifeist Wellness
Oct 31, 2026HOLDReiteratedC$0.0331Ratings0%-10.00%
INNO
InnoCan Pharma
Oct 31, 2026HOLDReiteratedC$2.0029Ratings――
SCYX
SCYNEXIS
Oct 31, 2026HOLDReiterated$4.0040Ratings――
SCNX
Scienture Holdings
Oct 31, 2026HOLDUpgraded$3.0022Ratings100%+21.10%
RPRX
Royalty Pharma
Oct 31, 2026BUYReiterated$77.008Ratings――
POM
PomDoctor Ltd. Unsponsored ADR
Oct 31, 2026SELLReiterated$1.5048Ratings100%+93.30%

Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.

Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

Google Medical - Pharmaceuticals activity FAQ

What is the performance of Google Medical - Pharmaceuticals's recommendations?
The percentage of profitable recommendations made by Google Medical - Pharmaceuticals is 48.65%, and the average return per transaction is 6.00%.
What stocks does Google Medical - Pharmaceuticals cover?
Google Medical - Pharmaceuticals mostly covers Adocia, Mayne Pharma Group, Integrated BioPharma stocks.
What was Google Medical - Pharmaceuticals's most profitable rating?
Google Medical - Pharmaceuticals’s most profitable rating was a buy on Definium Therapeutics stock on Feb 04, 2026. The return on the trade was 113.30%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here